Yoshiharu Ikeda
Chief Tech/Sci/R&D Officer bei SUMITOMO PHARMA CO., LTD.
Aktive Positionen von Yoshiharu Ikeda
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SUMITOMO PHARMA CO., LTD. | Director/Board Member | - | - |
Chief Tech/Sci/R&D Officer | 19.06.2015 | - | |
Corporate Officer/Principal | 08.11.2010 | 19.06.2015 | |
Primetals Technologies Ltd.
Primetals Technologies Ltd. Information Technology ServicesTechnology Services Primetals Technologies Ltd. operates as a engineering and plant construction company. It manures of steel and iron products. The company was founded in January 2015 and is headquartered in London, the United Kingdom. | Director/Board Member | - | - |
Director of Finance/CFO | - | - | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Director/Board Member | 01.01.2020 | - |
Karriereverlauf von Yoshiharu Ikeda
Ehemalige bekannte Positionen von Yoshiharu Ikeda
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - | - |
Statistik
International
Japan | 2 |
Vereinigte Staaten | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SUMITOMO PHARMA CO., LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Primetals Technologies Ltd.
Primetals Technologies Ltd. Information Technology ServicesTechnology Services Primetals Technologies Ltd. operates as a engineering and plant construction company. It manures of steel and iron products. The company was founded in January 2015 and is headquartered in London, the United Kingdom. | Technology Services |
- Börse
- Insiders
- Yoshiharu Ikeda
- Erfahrung